Barclays’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $181K | Buy |
62,627
+21,277
| +51% | +$45.4K | ﹤0.01% | 3748 |
|
|
2025
Q4 | $66.6K | Buy |
41,350
+2,044
| +5% | +$3.21K | ﹤0.01% | 4680 |
|
|
2025
Q3 | $66K | Sell |
39,306
-18,512
| -32% | -$30K | ﹤0.01% | 4707 |
|
|
2025
Q2 | $70K | Sell |
57,818
-52,319
| -48% | -$75.9K | ﹤0.01% | 4654 |
|
|
2025
Q1 | $140K | Sell |
110,137
-1,754
| -2% | -$4.58K | ﹤0.01% | 4266 |
|
|
2024
Q4 | $364K | Buy |
111,891
+13,138
| +13% | +$47.3K | ﹤0.01% | 4015 |
|
|
2024
Q3 | $325K | Buy |
98,753
+53,639
| +119% | +$209K | ﹤0.01% | 4038 |
|
|
2024
Q2 | $192K | Sell |
45,114
-36,628
| -45% | -$357K | ﹤0.01% | 3603 |
|
|
2024
Q1 | $1.2M | Sell |
81,742
-75,789
| -48% | -$1.15M | ﹤0.01% | 2970 |
|
|
2023
Q4 | $1.52M | Buy |
157,531
+23,258
| +17% | +$161K | ﹤0.01% | 3133 |
|
|
2023
Q3 | $626K | Buy |
134,273
+17,733
| +15% | +$88.3K | ﹤0.01% | 2659 |
|
|
2023
Q2 | $623K | Sell |
116,540
-23,608
| -17% | -$146K | ﹤0.01% | 2612 |
|
|
2023
Q1 | $1M | Buy |
140,148
+9,227
| +7% | +$55.6K | ﹤0.01% | 2728 |
|
|
2022
Q4 | $878K | Buy |
130,921
+69,866
| +114% | +$383K | ﹤0.01% | 2909 |
|
|
2022
Q3 | $211K | Sell |
61,055
-2,895
| -5% | -$11.1K | ﹤0.01% | 3167 |
|
|
2022
Q2 | $189K | Buy |
63,950
+24,893
| +64% | +$131K | ﹤0.01% | 3460 |
|
|
2022
Q1 | $344K | Sell |
39,057
-36,659
| -48% | -$405K | ﹤0.01% | 3122 |
|
|
2021
Q4 | $1.22M | Buy |
75,716
+8,683
| +13% | +$163K | ﹤0.01% | 2704 |
|
|
2021
Q3 | $1.4M | Sell |
67,033
-4,820
| -7% | -$116K | ﹤0.01% | 2569 |
|
|
2021
Q2 | $1.93M | Sell |
71,853
-35,002
| -33% | -$1.03M | ﹤0.01% | 2222 |
|
|
2021
Q1 | $3.4M | Buy |
106,855
+86,844
| +434% | +$2.11M | ﹤0.01% | 1846 |
|
|
2020
Q4 | $458K | Sell |
20,011
-6,631
| -25% | -$153K | ﹤0.01% | 3291 |
|
|
2020
Q3 | $672K | Sell |
26,642
-66,612
| -71% | -$1.82M | ﹤0.01% | 3007 |
|
|
2020
Q2 | $2.6M | Buy |
93,254
+76,230
| +448% | +$1.32M | ﹤0.01% | 1869 |
|
|
2020
Q1 | $98K | Sell |
17,024
-31,876
| -65% | -$289K | ﹤0.01% | 4816 |
|
|
2019
Q4 | $531K | Buy |
48,900
+19,033
| +64% | +$188K | ﹤0.01% | 4252 |
|
|
2019
Q3 | $381K | Sell |
29,867
-2,904
| -9% | -$41.8K | ﹤0.01% | 4463 |
|
|
2019
Q2 | $556K | Buy |
32,771
+14,342
| +78% | +$246K | ﹤0.01% | 4226 |
|
|
2019
Q1 | $331K | Buy |
+18,429
| New | +$319K | ﹤0.01% | 4443 |
|
|
2018
Q4 | – | Sell |
-16,507
| Closed | -$354K | – | 7168 |
|
|
2018
Q3 | $354K | Buy |
16,507
+13,637
| +475% | +$291K | ﹤0.01% | 4556 |
|
|
2018
Q2 | $59K | Sell |
2,870
-12,232
| -81% | -$276K | ﹤0.01% | 5557 |
|
|
2018
Q1 | $380K | Buy |
15,102
+6,820
| +82% | +$166K | ﹤0.01% | 4232 |
|
|
2017
Q4 | $157K | Buy |
8,282
+7,253
| +705% | +$135K | ﹤0.01% | 4895 |
|
|
2017
Q3 | $20K | Sell |
1,029
-5,940
| -85% | -$103K | ﹤0.01% | 5797 |
|
|
2017
Q2 | $122K | Buy |
6,969
+3,430
| +97% | +$65.4K | ﹤0.01% | 4770 |
|
|
2017
Q1 | $66K | Buy |
3,539
+870
| +33% | +$16.8K | ﹤0.01% | 5172 |
|
|
2016
Q4 | $54K | Sell |
2,669
-5,221
| -66% | -$131K | ﹤0.01% | 5113 |
|
|
2016
Q3 | $236K | Buy |
7,890
+7,860
| +26,200% | +$234K | ﹤0.01% | 3823 |
|
|
2016
Q2 | $1K | Sell |
30
-1,465
| -98% | -$33K | ﹤0.01% | 6125 |
|
|
2016
Q1 | $27K | Buy |
1,495
+959
| +179% | +$18.3K | ﹤0.01% | 5094 |
|
|
2015
Q4 | $16K | Sell |
536
-8,830
| -94% | -$268K | ﹤0.01% | 5266 |
|
|
2015
Q3 | $197K | Buy |
9,366
+8,768
| +1,466% | +$275K | ﹤0.01% | 4142 |
|
|
2015
Q2 | $22K | Sell |
598
-430
| -42% | -$14.1K | ﹤0.01% | 5622 |
|
|
2015
Q1 | $32K | Sell |
1,028
-17,075
| -94% | -$579K | ﹤0.01% | 5582 |
|
|
2014
Q4 | $634K | Buy |
18,103
+17,850
| +7,055% | +$445K | ﹤0.01% | 3632 |
|
|
2014
Q3 | $5K | Sell |
253
-182
| -42% | -$3.76K | ﹤0.01% | 7187 |
|
|
2014
Q2 | $9K | Buy |
435
+194
| +80% | +$4.08K | ﹤0.01% | 6880 |
|
|
2014
Q1 | $7K | Buy |
241
+150
| +165% | +$5.3K | ﹤0.01% | 7080 |
|
|
2013
Q4 | $2K | Buy |
+91
| New | +$2.38K | ﹤0.01% | 7362 |
|
Other funds holding MGNX
AC
VCM
RCM
WA
Barclays's MGNX Position: Q1 2026 in Review
Barclays increased its MacroGenics (MGNX) stake by 51% in Q1 2026, buying an estimated $45.4K and bringing the position to 62,627 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #3748.
Barclays first reported a position in MGNX in Q4 2013 and has held it in 49 quarters since. The position peaked at $3.4M in Q1 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.
- Barclays held 62,627 shares of MacroGenics worth $181K as of Q1 2026.
- Barclays bought 21,277 MacroGenics shares in Q1 2026, an estimated $45.4K.
- MacroGenics made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3748 holding.
- Barclays first reported a position in MacroGenics in Q4 2013 and has held it in 49 quarters since.
- Barclays's MacroGenics position peaked at $3.4M in Q1 2021.
- 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.